Descripción de la empresa: |
IOmet Pharma is a privately-owned drug discovery company based in Edinburgh, UK. Founded in 2008, IOmet is focused on the development of innovative medicines for the treatment of cancer, with particular emphasis on the fields of cancer immunotherapy and cancer metabolism. IOmet has a comprehensive pipeline of IDO, TDO and dual-acting IDO/TDO inhibitors and novel GLUT1 inhibitors. IOmet’s team has a proven track record of success in bringing small molecules from discovery phase to the clinic, and is advised by internationally-renowned experts in the fields of cancer immunotherapy and cancer metabolism. |